Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
44.1M
-
Shares change
-
+3.79M
-
Total reported value, excl. options
-
$732M
-
Value change
-
+$63.1M
-
Put/Call ratio
-
0.23
-
Number of buys
-
67
-
Number of sells
-
-50
-
Price
-
$16.62
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q1 2022
143 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q1 2022.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.1M shares
.
Largest 10 shareholders include Bellevue Group AG (4.67M shares), Avidity Partners Management LP (3.52M shares), BlackRock Inc. (2.9M shares), FRANKLIN RESOURCES INC (2.49M shares), Point72 Asset Management, L.P. (2.27M shares), STATE STREET CORP (2.24M shares), VANGUARD GROUP INC (2.23M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.86M shares), VICTORY CAPITAL MANAGEMENT INC (1.75M shares), and Logos Global Management LP (1.61M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.